Edition:
United Kingdom

People: Beijing Enterprises Medical and Health Industry Group Ltd (2389.HK)

2389.HK on Hong Kong Stock

0.24HKD
22 Jul 2019
Change (% chg)

HK$-0.00 (-0.41%)
Prev Close
HK$0.24
Open
HK$0.24
Day's High
HK$0.24
Day's Low
HK$0.24
Volume
4,020,000
Avg. Vol
7,204,800
52-wk High
HK$0.40
52-wk Low
HK$0.20

Liu, Xue Heng 

Mr. Liu Xue Heng is Joint Chief Executive Officer, Executive Director of Genvon Group Limited. He is currently a member of the Investment and Risk Management Committee of the Company. Mr. Liu obtained his MBA from the Cambridge University of the United Kingdom. Mr. Liu has extensive experience in equity investment, corporate finance, IPO listings and mergers and acquisitions. He is a co-founder of Partners Capital International Limited and Vision Finance Group Limited. Mr. Liu is currently an executive director of Vision Finance Group Limited and BPHL (stock code: 925) as well as an executive director and the chief executive officer of Bestway International Holdings Limited (a company whose shares are listed on the Stock Exchange, stock code: 718). Mr. Liu was an independent nonexecutive director of Guangshen Railway Co., Limited (a company whose shares are listed on the Stock Exchange, stock code: 525) during the period from 2 June 2011 to 29 May 2014.

Basic Compensation

Total Annual Compensation, HKD 36,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD --
Fiscal Year Total, HKD 36,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --